Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effect of apomorphine on pain perception in Parkinson's disease (clinical and PET study)
2006-005318-11Phase 2Completed
- Sponsor
- Centre hospitalier universitaire de Toulouse
- Start
- May 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of apomorphine in Parkinson's disease (PD) (4 arms), sponsored by Centre hospitalier universitaire de Toulouse. Primary endpoint: Subjective thermal nociceptive threshold. Started May 2007; status: completed.
02
Drugs
apomorphine
03
Conditions
Parkinson's disease (PD)
Beyond the preview
Go deeper on 2006-005318-11.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-005318-11.